LAIR1 and cancer: Collagen, which is a component of the ECM released by cancer-associated fibroblasts (CAFs), tumor cells and macrophages, has been demonstrated to impair the immune response by acting as an immune checkpoint when interacting with leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) on immune cells (83).